China, Sept. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The SAMD9/STAT1 axis regulates tumor-promoting mechanisms of pancreatic cancer stem cells in a circadian'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132050
Registration Time: 2026/09/09
Type: Observational study
Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334514
Published by HT Digital Content Services with permission from Health Daily Digest....